§ COMPARE REGULATORS

EU MDR vs NMPA: Europe and China Medical Device Regulation

Compare EU MDR CE marking with NMPA registration — Notified Bodies vs CMDE, UDI requirements, clinical evidence, and post-market surveillance.

EMA

European Medicines Agency

European Union

The EMA coordinates the EU regulatory framework for medical devices under EU MDR 2017/745 and IVDR 2017/746. While Notified Bodies conduct conformity assessments, the EMA and European Commission set p

CLASSES

Class I, IIa, IIb, III

PATHWAY

CE marking via Notified Body

KEY FUNCTIONS
  • EU MDR / IVDR framework coordination
  • EUDAMED database oversight
  • Notified Body designation support
  • CE marking pathway
  • Vigilance and post-market surveillance

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

MedFlux monitors both EMA and NMPA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS